Fig. 1.
Fig. 1. Characterization of angiostatin preparations used in this study. (A) Ten micrograms of rmAst, rhAst, and ehAst were run under reducing conditions in a 9% polyacrylamide gel and stained with Coomassie blue. Mr = relative molecular mass × 1,000. (B) hPlg and rhAst were analyzed by Western blotting under nonreducing conditions using mouse MoAbs 36E6 and 42B12 directed against kringles 1-3/LBSI and kringle 5, respectively.Mr = relative molecular mass × 1,000. (C) Elution profile of rmAst after purification by HPLC.

Characterization of angiostatin preparations used in this study. (A) Ten micrograms of rmAst, rhAst, and ehAst were run under reducing conditions in a 9% polyacrylamide gel and stained with Coomassie blue. Mr = relative molecular mass × 1,000. (B) hPlg and rhAst were analyzed by Western blotting under nonreducing conditions using mouse MoAbs 36E6 and 42B12 directed against kringles 1-3/LBSI and kringle 5, respectively.Mr = relative molecular mass × 1,000. (C) Elution profile of rmAst after purification by HPLC.

Close Modal

or Create an Account

Close Modal
Close Modal